Neo Borocillina Gola Dolore Senza Zucchero Gusto Arancia E Miele (Flurbiprofen)

Flurbiprofen blocks the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the production of prostaglandins—chemical mediators that promote inflammation, pain, and fever. Lower prostaglandin levels diminish these symptoms.

The appropriate dose of flurbiprofen is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and overall health. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Flurbiprofen is generally avoided in the third trimester of pregnancy because NSAIDs can affect fetal cardiovascular development. Safety during early pregnancy and lactation is not well established, so clinicians should weigh potential risks and benefits before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Flurbiprofen has a similar mechanism to ibuprofen but is often considered more potent on a milligram‑per‑milligram basis. Both share comparable safety profiles, though flurbiprofen may have a slightly higher risk of gastrointestinal irritation, requiring careful patient selection.

Store Neo Borocillina Gola Dolore Senza Zucchero Gusto Arancia E Miele at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and avoid exposure to direct sunlight.

The product is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food may reduce stomach upset. Patients should follow the dosing schedule prescribed by their healthcare provider.

The most serious risks include gastrointestinal bleeding or ulceration, severe skin reactions such as Stevens‑Johnson syndrome, renal impairment, hepatic injury, and increased cardiovascular events like heart attack or stroke. Patients should seek immediate medical attention if they experience signs of these conditions.

Flurbiprofen should be avoided in individuals with a known hypersensitivity to the drug or other NSAIDs, active gastrointestinal ulcer or bleeding, severe renal or hepatic impairment, and in the third trimester of pregnancy. Caution is also advised for patients with uncontrolled hypertension or cardiovascular disease.